Quest Diagnostics Incorporated (DGX) : Fridays money flow indicated an uptick to downtick ratio was at 1.47. The total value of inflow transactions on upticks was $33.63 million, whereas, the total value of outflow trades on downticks was $22.82 million. The total money flow was $10.81 million, which shows a mild bullish bias. The total money flow into the stock in block trades was $8.81 million. The total value of the trades done on upticks was $8.81 million. Quest Diagnostics Incorporated (DGX) was trading with a -0.56% change over previous days close. It fell $0.46 during the day and reached $82.36. The stock was -0.75% compared to the previous weeks close.
The company Insiders own 1.5% of Quest Diagnostics Incorporated shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -5.11% . Institutional Investors own 91.79% of Quest Diagnostics Incorporated shares. During last six month period, the net percent change held by insiders has seen a change of -6.74%.
In a related news,The director of Quest Diagnostics Inc, Britell Jenne K sold 4,000 shares at $84.76 on August 19, 2016. The Insider selling transaction had a total value worth of $339,040. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Quest Diagnostics Incorporated (NYSE:DGX): The stock opened at $82.67 and touched an intraday high of $83.22 on Friday. During the day, the stock corrected to an intraday low of $82.295, however, the bulls stepped in and pushed the price higher to close in the green at $83.04 with a gain of 0.83% for the day. The total traded volume for the day was 2,303,179. The stock had closed at $82.36 in the previous trading session.
Quest Diagnostics Incorporated (DGX) : During the past 4 weeks, traders have been relatively bearish on Quest Diagnostics Incorporated (DGX), hence the stock is down -2.95% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.43% relative to the S&P 500. The stock has risen by 0.07% in the past week indicating that the buyers are active at lower levels, but the stock is down -3.08% in the past 4 weeks.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.